Introduction: Acute variceal bleeding in liver cirrhosis is an immediate life-threatening condition and amajor complication of portal hypertension associated with higher morbidity, mortality and hospital costs than any other causes of UGI bleeding. Therefore, early stratification and initiation of therapy based on several factors can reduce mortality associated with it. We aimed to study the predictors of mortality in acute variceal bleeding in LC.
INTRODUCTION
Acute variceal bleeding is an immediate life-threatening major complication of portal hypertension associated with higher morbidity, mortality and hospital costs. It occurs at a yearly rate of 5%-15% in cirrhotic patients. 1 The most important predictor of bleeding is the size of thevarices, with the highest risk of first bleeding (15% per year) occurring in patients with large varices. 2 Up to 25% of the patients with newly diagnosed varices will experience variceal bleeding within two years. 3 Approximately 30%-50% of patients with liver cirrhosis (LC) die within six weeks of the first variceal bleeding episode. 4 While most patients with cirrhosis form varices at some point in their disease. However, only one third will bleed among them.
The aim of the study was to find the factors associated with mortality in patients with LC presenting as acute variceal bleeding at tertiary care hospital.
METHODS
This was an observational prospective study. It was conducted at Bir Hospital, NAMS (National Academy of Medical Sciences), Kathmandu, Nepal from April 1, 2016 to May 30, 2017. Ethical approval was taken from the Institutional Review Board (IRB) of the Bir Hospital, NAMS.
Consecutive patients of upper gastrointestinal (UGI) bleeding (hematemesis, coffee ground vomitus, hematochezia, or melena) were subjected to endoscopic evaluation after stabilization of hemodynamics. All patients with bleeding varices were included inthe study. Non-cirrhotic portal hypertensive patients, patients aged less than 18 years and patients with HCC or other co-morbidities were excluded. Packed red cell transfusion was done to maintain the haemoglobin level between 8-9 mg/dL. Platelets rich plasma and fresh frozen plasma were transfused whenever required and required units were noted. All the basic investigations were obtained to calculate CTP and MELD score. After stabilization, Pantoprazole 40 mg IV loading dose followed by8 mgper hour was infused, IV Octreotide 50 mcg loading dose followed by 50 mcg per hour was infused for 5 days. All patients underwent UGI endoscopy followed by endoscopic variceal ligation (EVL). All causes of in-hospital mortality were recorded. The patients were divided into survivor and mortality groups and different variables were compared.
Minimum required sample size for this study was calculated by the formula,
Where, N=required sample size, Za=Variate corresponding to desired reliability level (1.96 for 95% reliability), P=Estimated proportion in the population (5% for this study) 2 , Q=100-P (if P is in%) and d=Maximum tolerable error (5%). With this formula minimum required sample size was 72.
RESULTS
A total of 97 patients presented with variceal bleeding within the study period. 22 patients were excluded, and the cause of exclusion were non-cirrhotic portal fibrosis related bleed (n=7), extra-hepatic portal obstruction (n=9), patients aged under 18 (n=6). Finally,75 patients were available for the analysis. There was male preponderance with M: Fratio of 2.1:1. The mean age of the patients was 52.5 year.There were 9 deaths during the study period. The baseline characteristics of the study population are shown (Table 1) . The mean hospital stay in the study population was 7.79 days. In the mortality group, total hospital stay was 7.11±5.75daysand in a survival group it was 7.88±4.32days (P = 0.63). The study population according to CTP score was as follows: CTP-A was 4 (5.33%), CTP-B was 25 (33.33%) and CTP -C was 46 (61.33%). The mean CTP score in a study population was 10.17±SD 1.66 whereas the mean MELD score was 20.40±8.29. The comparisons of predictors of mortalityin non-survivors (mortality) and in survivors are shown (Table 2) . Using chi square test; past history of EVL (p=0.03), presence of HRS (p=0.007), HE (hepatic encephalopathy) (p=0.034), early rebleed (p=0) and co-morbidity (p=0.007) were associated with significant mortality. Presence of spontaneous bacterial peritonitis (SBP) was not associated with significant mortality (p=0.59) in our study population.
By multivariate analysis, higher CTP, and higher serum creatinine were an independent risk factor of in hospital mortality (Table 2) .Receiver Operator Curve (ROC) for predicting accuracy of mortality is shown (Table 4) . 
DISCUSSION
The incidence of in-hospital mortality due to variceal bleeding in patients with LC was 12% in our study which is consistent with several other studies. 5 In a large series of 403 patients with variceal bleeding in LC, Del Olmo et al found a mortality rate of 7.4%. In different studies by several authors including Chalasaniet al, Faisal et al, Ahmed et al,Romcea et al, all of them noted in-hospital mortality of 14.2%, 8.7%, 8%, and 2.93% respectively.
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Due to advancement in the endoscopic procedures including the recent modalities like esophageal stenting and more availability of interventional procedures like transjugular intravenous portosystemic stent shunt (TIPS), significant fall in mortality is expected over time.
In our study, the highest mortality was observed in CTP-C which was 8 (88.8%) followed by CTP-B having one (11.1%) death. However, no mortality was seen in CTP-A. It suggests that the degree of liver dysfunction is an important predictor of variceal bleeding and it also reflects mortality.
In our study, majority of patients presented to hospitals were more severe as evidenced by CTP-C in comparison to other study by Choi YJ et al where majority i.e. 273 (42.5%) of patients were CTP-B followed by 180 (28.0%)CTP-C.
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A MELD score >19 was associated with 20 percent mortality rate, while a MELD score <11 was associated with <5 percent mortality rate. 10 This scoring tool is potentially useful threshold for defining a high risk of death.MELD score has also been shown to be the best predictors of mortality based on ROC in our study which is consistent witha study by Reverter et al. The study conducted by Faisal et al reported that the non-survivors had higher serum bilirubin (2.4 vs. 1.6 mg/dL; P=0.032) and serum creatinine (2.1 vs. 1.1 mg/ dL; P=0.02) which is also consistent with our study. Using univariate logistic regression analysis for mortality; CTP score, MELD score, AST, Serum creatinine, transfusion of fresh frozen plasma, inotrope infusion, early re-bleed, development of HRS and HE were associated with significant mortality in our study.
However, on multivariate logistic regression analysis, the independent predictors of mortality were noted only in higher CTP score and higher serum creatinine.
The independent predictors of mortality on multiple logistic regression analysis seen in other study were also similar to our study. 8, 12, 13 These predictors were serum creatinine >1.5 mg/dL, serum bilirubin >3 mg/ dL and presence of HE.
We also compared CTP and MELD score for largest area under the receiver operator curve (AUROC) and the values obtained for MELD score and CTP score were 0.857 and 0.748 respectively which was also consistent with study by Mohmmad et al, where AUROC for CTP score was >0.8. 13 Our study showed MELD score to be more accurate predictor of mortality as compared to CTP score.
There are some limitations of our study including small sample size; no follow up after the patients were discharged.
CONCLUSIONS
CTP-C and high serum creatinine are the two most important factors associated with mortality, but the accurate predictor of mortality was higher MELD score. These factors can be used in the resource limited setting in order to stratify the higher risk group.
